The efficacy and safety of tocilizumab (trade name: Actemra) in RA patients.
Not Applicable
Recruiting
- Conditions
- Rhumatoid arthritis
- Registration Number
- JPRN-UMIN000002843
- Lead Sponsor
- Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with a history of sensitivity to any of the ingredients of Actemra 2)Patients with a serious concomitant infection 3)Patients with active tuberculosis 4)Patients with a lymphocyte count less than 500/ mcL 5)Patients with HCV, HBV or HIV infections 6)Other patients whom the investigator considers to be unsuitable for the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method